Mylan and Teva stocks rise on report about Amazon's pharmacy aims - MarketWatch
Exclusive: Teva Pharm in talks to co-produce COVID-19 vaccines, CEO says
Israel stocks up, led by Teva, Bezeq - MarketWatch
Three health-care deals today are paying huge premiums - MarketWatch
The Teva Pharmaceutical Industries Limited (NYSE:TEVA) Yearly Results Are Out And Analysts Have Published New Forecasts
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )
Limor Peleg - Director, Product network & Material Strategy - Teva Pharmaceuticals | LinkedIn
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Israel stocks at record; Biogen remarks cost Teva - MarketWatch
Teva Stock Falls After Earnings and Revenue Miss Estimates | Barron's
Teva Pharmaceutical Industries Ltd. ADR, TEVA Advanced Chart - (NYS) TEVA, Teva Pharmaceutical Industries Ltd. ADR Stock Price - BigCharts.com
Trump makes the case for chloroquine as a COVID-19 treatment, though it has not been approved by the FDA for this illness - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Teva Stock Has Crumbled, and Chairman Sol Barer Is Buying Up Shares | Barron's
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Israel stocks up; FTC eyes Teva-Cephalon deal - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
